<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>6</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Cobalt Chloride Induces Necroptosis in Human Colon Cancer HT-29 Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2569</FirstPage>
			<LastPage>2574</LastPage>
			<ELocationID EIdType="pii">30780</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Necroptosis, also known as “programmed necrosis”, has emerged as a critical factor in a variety of pathologicaland physiological processes and is considered a cell type-specific tightly regulated process with mechanismsthat may vary rather greatly due to the change of cell line. Here we used HT-29, a human colon cancer cellline, to establish a necroptosis model and elucidate associated mechanisms. We discovered that cobalt chloride,a reagent that could induce hypoxia-inducible factor-1α(HIF1α) expression and therefore mimic the hypoxicmicroenvironment of tumor tissue in some aspects induces necroptosis in HT-29 cells when caspase activityis compromised. On the other hand, apoptosis appears to be the predominant death form when caspases arefunctioning normally. HT-29 cells demonstrated significantly increased RIPK1, RIPK3 and MLKL expressionin response to cobalt chloride plus z-VAD treatment, which was accompanied by drastically increased IL1αand IL6 expression, substantiating the notion that necrosis can induce profound immune reactions. The RIPK1kinase inhibitor necrostatin-1 and the ROS scavenger NAC each could prevent necrosis in HT-29 cells andthe efficiency was enhanced by combined treatment. Thus by building up a necroptosis model in human coloncancer cells, we uncovered that mechanically RIP kinases collaborate with ROS during necrosis promoted bycobalt chloride plus z-VAD, which leads to inflammation. Necroptosis may present a new target for therapeuticintervention in cancer cells that are resistant to apoptotic cell death.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">cobalt chloride</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">colon cancer cells</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Necroptosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Rip1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ROS</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_30780_6a1c5088ec886ee509e3d73b61247538.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
